Edesa Biotech

(NASDAQ) EDSA

Current Price$10.03

Market Cap$115.96M

Since IPO (2019)-64%

5 Year-69%

1 Year+553%

1 Month+143%

Edesa Biotech Financials at a Glance

Market Cap

$115.96M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.44M

EPS (TTM)

$-1.34

P/E Ratio

-9.73

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$10.03

Volume

211,423.395

Open

$12.88

Price

$10.03

Volume

211,423.395

Open

$12.88

Previous Close

$13.05

Daily Range

$10.40 - $13.30

52-Week Range

$0.72 - $20.32

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$10.03

Volume

211,423.395

Open

$12.88

Previous Close

$13.05

Daily Range

$10.40 - $13.30

52-Week Range

$0.72 - $20.32

EDSA News

Edesa Biotech Posts Narrower Loss in Q3

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Edesa Biotech

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Pardeep Nijhawan, MD

Website

www.edesabiotech.com

Headquarters

Markham, ON L3R 5H6, CA

EDSA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-81%

Return on Capital

-1%

Return on Assets

-84%

Earnings Yield

-10.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$115.96M

Shares Outstanding

8.89M

Volume

211.42K

Avg. Volume

4.57M

Financials (TTM)

Gross Profit

$119.27K

Operating Income

$7.91M

EBITDA

$7.07M

Operating Cash Flow

$7.32M

Capital Expenditure

$0.00

Free Cash Flow

$7.32M

Cash & ST Invst.

$10.79M

Total Debt

$0.00

Edesa Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$25.87K

N/A

Gross Margin

0.00%

N/A

Market Cap

$115.96M

N/A

Market Cap/Employee

$7.25M

N/A

Employees

N/A

Net Income

$4.22M

-165.2%

EBITDA

$4.27M

-173.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$10.00M

-28.0%

Accounts Receivable

$216.47K

-43.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-84.33%

N/A

Return on Invested Capital

-1.08%

N/A

Free Cash Flow

$2.02M

+13.6%

Operating Cash Flow

$2.02M

+13.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$21.40+4.75%

TRAWTraws Pharma, Inc.

TRAWTraws Pharma, Inc.$1.89+0.53%

OSRHOSR Holdings, Inc.

OSRHOSR Holdings, Inc.$0.54-5.93%

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$1.26+5.00%

IMRNImmuron Limited

IMRNImmuron Limited$1.00-2.48%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.81+10.98%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.42-2.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.70-0.02%

TET1 Energy Inc.

TET1 Energy Inc.$6.61+0.17%

POETPoet Technologies

POETPoet Technologies$14.64-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.03+0.00%

FIGFigma

FIGFigma$23.98+0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.31-0.03%

AIIORobo.ai

AIIORobo.ai$5.69+0.41%

Questions About EDSA

What is the current price of Edesa Biotech?

Edesa Biotech is trading at $10.47 per share.

What is the 52-week range for Edesa Biotech?

Over the past 52 weeks, Edesa Biotech has traded between $0.72 and $20.32.

How much debt does Edesa Biotech have?

As of the most recent reporting period, Edesa Biotech reported total debt of N/A.

How much cash does Edesa Biotech have on hand?

Edesa Biotech reported $10.00M in cash and cash equivalents in its most recent financial results.

What is Edesa Biotech’s dividend yield?

Edesa Biotech does not currently have a dividend yield.

Edesa Biotech

Edesa Biotech Financials at a Glance

EDSA News

Edesa Biotech Posts Narrower Loss in Q3

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Edesa Biotech

EDSA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Edesa Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EDSA

What is the current price of Edesa Biotech?

What is the 52-week range for Edesa Biotech?

How much debt does Edesa Biotech have?

How much cash does Edesa Biotech have on hand?

What is Edesa Biotech’s dividend yield?

Premium Investing Services